BPC-157 + TB-500 | Packaging: 10 mg, Primary purpose: Muscle and tendon recovery, Secondary purpose: Joint healing and reduction of inflammation

New Free

BPC-157 + TB-500 – recovery and regeneration

The synergistic combination of BPC-157 and TB-500 supports angiogenesis, collagenogenesis and soft tissue regeneration. Ideal for overload, microtears and high training volumes. It helps a faster return to heavy loading and better technique due to reduced discomfort. Suitable for athletes in strength and endurance sports, as well as for fitness enthusiasts who want consistency without long breaks.

An exceptionally powerful agent for recovery, rejuvenation and a marked increase in tone in men and women.

0 reviews • Write a review

€ 79.00

Ex Tax: € 79.00

Qty

Add to Cart

Buy Now Question?

Add to Wish List

Ask a Question about this Product

Shipping

Secure and safe worldwide delivery! If the product is on stock - average delivery time is 2-3 days in Eastern Europe, 3-7 days in Western Europe and 1-3 weeks world wide!

Improved storage formula

Improved storage formula - increased stability and extended shelf life!

Quality Control & Tests

High-quality product! All peptides branded MyPeptid are produced in 100% laboratory conditions and have purity above 98%. Our products are tested at JINOSHIK, Analiza Białek and other independent, established laboratories with high standards!

Tags: Възстановяване на мускули и сухожилия

Product information

This combination helps the body restore damaged areas, accelerating repair and the formation of new blood-supplying structures, without using technical terms.

Context and biological profile

In the context of tissue regeneration and inflammatory reactions, control of angiogenesis and cytoskeletal remodeling is a central goal in translational research. BPC-157 + TB-500 represents a combination of peptides: BPC‑157 is a gastric pentadecapeptide from the class of protective peptides, and TB‑500 is a synthetic analogue of a fragment of thymosin β‑4, associated with regulation of the actin cytoskeleton and mobility of tissue elements. They are being investigated as tools to modulate restorative pathways and cell migration in preclinical models.

Mechanism of action

The combination affects the microenvironment through interaction with growth factors and signaling pathways, including modulation of oxidative status and promotion of VEGF‑related responses and remodeling of the actin network; this leads to increased cell migration, changes in matrix organization, and locally increased vascularization. Central and peripheral effects interacting at the level of cytokine balance and matrix metalloproteinase activity support structural recovery in controlled models.

Research data

Study	Model	n	Duration	Key observed outcomes
BPC‑157 tendon study	early postoperative rat model	30	2–4 weeks	increased tendon strength and structural organization in comparative analysis
TB‑500 wound model	mouse skin wound model	24	7–14 days	accelerated epithelialization and increased microvascularization
Combined preclinical analysis	tissue reconstructions in rodents	40	2–6 weeks	synergistic effects on cell migration and markers of angiogenesis

The data are predominantly preclinical; quantitative effects vary between models and protocols.

Use in scientific research

The combination is studied in fields such as tissue regeneration, orthopedics, recovery physiology, and wound pharmacology. All observations derive from controlled laboratory experiments and preclinical publications; no recommendations are made for uncontrolled use. For further literature: BPC-157 + TB-500, PubMed: BPC‑157 literature, PubMed: thymosin beta‑4 literature.

The content is provided for educational and research purposes only.